These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38159995)

  • 1. Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells
    Oka D; Sekine Y; Tsuji Y; Nakayama H; Miyazawa Y; Arai S; Koike H; Suzuki K
    Anticancer Res; 2024 Jan; 44(1):93-98. PubMed ID: 38159995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.
    Nakayama H; Sekine Y; Oka D; Miyazawa Y; Arai S; Koike H; Matsui H; Shibata Y; Suzuki K
    Prostate; 2022 Feb; 82(3):314-322. PubMed ID: 34843630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
    Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Oka D; Nakazawa S; Tsuji Y; Nakayama H; Suzuki K
    Anticancer Res; 2023 Dec; 43(12):5377-5386. PubMed ID: 38030198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
    Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
    BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
    Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
    J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
    Sivaprasad U; Abbas T; Dutta A
    Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism.
    Sekine Y; Demosky SJ; Stonik JA; Furuya Y; Koike H; Suzuki K; Remaley AT
    Mol Cancer Res; 2010 Sep; 8(9):1284-94. PubMed ID: 20671065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism.
    Sekine Y; Nakayama H; Miyazawa Y; Kato H; Furuya Y; Arai S; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
    Oncol Lett; 2018 Mar; 15(3):3167-3172. PubMed ID: 29435052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins.
    Furuya Y; Sekine Y; Kato H; Miyazawa Y; Koike H; Suzuki K
    Prostate Int; 2016 Jun; 4(2):56-60. PubMed ID: 27358845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simvastatin on castration-resistant prostate cancer cells.
    Kim JH; Cox ME; Wasan KM
    Lipids Health Dis; 2014 Mar; 13():56. PubMed ID: 24666612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive inhibitory effects of simvastatin and enzalutamide on androgen-sensitive LNCaP and VCaP prostate cancer cells.
    Syvälä H; Pennanen P; Bläuer M; Tammela TL; Murtola TJ
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):46-50. PubMed ID: 27833018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin.
    Korte V; Gademann G; Gawish A; Ochel HJ
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4509-4514. PubMed ID: 36127484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes.
    Mirzaei A; Rashedi S; Akbari MR; Khatami F; Aghamir SMK
    J Cell Mol Med; 2022 May; 26(9):2728-2740. PubMed ID: 35366048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
    Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT
    Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol.
    Hermann RM; Wolff HA; Jarry H; Thelen P; Gruendker C; Rave-Fraenk M; Schmidberger H; Christiansen H
    Radiat Oncol; 2008 Jul; 3():19. PubMed ID: 18625043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
    Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Sáez-Martínez P; Gómez-Gómez E; León-González AJ; Fuentes-Fayos AC; Yubero-Serrano EM; Requena-Tapia MJ; López M; Castaño JP; Gahete MD; Luque RM
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e696-e710. PubMed ID: 33247590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor.
    Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K
    Biochem Biophys Res Commun; 2008 Jul; 372(2):356-61. PubMed ID: 18489904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence.
    Zheng X; Cui XX; Gao Z; Zhao Y; Lin Y; Shih WJ; Huang MT; Liu Y; Rabson A; Reddy B; Yang CS; Conney AH
    Cancer Prev Res (Phila); 2010 Jan; 3(1):114-24. PubMed ID: 20051379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
    Murtola TJ; Pennanen P; Syvälä H; Bläuer M; Ylikomi T; Tammela TL
    Prostate; 2009 Jun; 69(9):1017-23. PubMed ID: 19301305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.